Atria Investments’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Atria Investments’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-22,518	Closed	-$1.06M	–	417
2015 Q3	$1.06M	Buy	22,518 +1,472	+7%	+$88.7K	0.15%	105
2015 Q2	$1.31M	Buy	21,046 +576	+3%	+$35.9K	0.15%	97
2015 Q1	$1.26M	Sell	20,470 -2	-0%	-$119	0.14%	102
2014 Q4	$1.1M	Buy	20,472 +2,756	+16%	+$151K	0.12%	145
2014 Q3	$939K	Buy	17,716 +2,246	+15%	+$114K	0.1%	179
2014 Q2	$803K	Sell	15,470 -4,184	-21%	-$202K	0.08%	208
2014 Q1	$920K	Buy	19,654 +2,426	+14%	+$115K	0.09%	185
2013 Q4	$758K	Buy	17,228 +2,688	+18%	+$112K	0.08%	219
2013 Q3	$560K	Sell	14,540 -278	-2%	-$10.5K	0.06%	261
2013 Q2	$522K	Buy	+14,818	New	+$500K	0.06%	175

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return

Atria Investments's XPH Position: Q4 2015 in Review

Atria Investments sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2015, closing a stake of 22,518 shares — an estimated $1.06M sold.

Atria Investments first reported a position in XPH in Q2 2013 and held it in 10 quarters. The position peaked at $1.31M in Q2 2015. 76 funds tracked by Wall St. Rank hold XPH as of Q4 2015.

Atria Investments reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2015 after selling out during the quarter.
Atria Investments sold 22,518 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2015, an estimated $1.06M.
Atria Investments first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 10 quarters.
Atria Investments's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.31M in Q2 2015.
76 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2015.

Based on Atria Investments's 13F filing for Q4 2015, filed 14 Jan 2016.